a developer of pharmaceutical products
Industry Biotechnology
A.I.dvisor tells us that ABEO and SCPH have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ABEO and SCPH's prices will move in lockstep.
Ticker / NAME | Correlation To ABEO | 1D Price Change % | ||
---|---|---|---|---|
ABEO | 100% | -4.21% | ||
SCPH - ABEO | 29% Poorly correlated | -2.75% | ||
XNCR - ABEO | 29% Poorly correlated | -3.14% | ||
GLPG - ABEO | 28% Poorly correlated | -1.20% | ||
XENE - ABEO | 27% Poorly correlated | -0.47% | ||
MLEC - ABEO | 26% Poorly correlated | +8.26% | ||
More |
Ticker / NAME | Correlation To ABEO | 1D Price Change % |
---|---|---|
ABEO | 100% | -4.21% |
pharmaceuticals theme (167 stocks) | 17% Poorly correlated | +0.82% |
pharmaceuticals generic theme (8 stocks) | 4% Poorly correlated | -0.45% |